Anna Galkin
- Molecular Biology
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Immunology
- Biochemistry top 5%
- Co-authors
- Pia VuorelaLeena LaitinenHeikki VuorelaPäivi TammelaPeter G. SchultzAdyary FallareroDavid B. AgusTami Hood
- Topics
- Immune cells in cancer (5 papers)Cancer Immunotherapy and Biomarkers (4 papers)Analytical Chemistry and Chromatography (3 papers)
- Cited by
- BiochemistryOncologyCancer Research
- Partner nations
- United StatesFinlandNorway
In The Last Decade
Anna Galkin
23 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 96
- Molecular Biology 493
- Oncology 252
- Pulmonary and Respiratory Medicine 228
- Immunology 161
- Biochemistry 154
Countries citing papers authored by Anna Galkin
This map shows the geographic impact of Anna Galkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Galkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Galkin more than expected).
Fields of papers citing papers by Anna Galkin
This network shows the impact of papers produced by Anna Galkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Galkin. The network helps show where Anna Galkin may publish in the future.
Co-authorship network of co-authors of Anna Galkin
This figure shows the co-authorship network connecting the top 25 collaborators of Anna Galkin. A scholar is included among the top collaborators of Anna Galkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Galkin. Anna Galkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 53 | |
| 3 | 49 | |
| 4 | 7 | |
| 5 | 1 | |
| 6 | Abstract 11102: Gb002, A Novel Inhaled Pdgfr Kinase Inhibitor, Demonstrates Efficacy in the Su5416 Hypoxia Rat Model of Pulmonary Arterial Hypertension (pah) | 4 |
| 7 | 0 | |
| 8 | 5 | |
| 9 | 15 | |
| 10 | 19 | |
| 11 | 69 | |
| 12 | Development of an automated 7-day 96-well Caco-2 cell culture model. | 11 |
| 13 | 1 | |
| 14 | 12 | |
| 15 | 289 | |
| 16 | 37 | |
| 17 | 113 | |
| 18 | 110 | |
| 19 | 32 | |
| 20 | 69 |
About Anna Galkin
Anna Galkin is a scholar working on Biochemistry, Complementary and alternative medicine and Cancer Research, having authored 28 papers that have together received 1.1k indexed citations. Recurring topics across this work include Immune cells in cancer (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Analytical Chemistry and Chromatography (3 papers). The work is most often cited by research in Biochemistry (154 citations), Oncology (252 citations) and Cancer Research (119 citations). Anna Galkin has collaborated with scholars based in United States, Finland and Norway. Frequent co-authors include Pia Vuorela, Leena Laitinen, Heikki Vuorela, Päivi Tammela, Peter G. Schultz, Adyary Fallarero, David B. Agus, Tami Hood, Nanxin Li and Yi Liu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.